Free Trial

Cannabis Stocks To Watch Now - May 5th

Tilray Brands logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • MarketBeat's stock screener identifies Tilray Brands (TLRY), Akanda (AKAN) and Canopy Growth (CGC) as the cannabis stocks to watch because they recorded the highest dollar trading volume among cannabis names in recent days.
  • Cannabis stocks carry high volatility and regulatory risk but potential for rapid growth as legalization expands; Tilray and Canopy Growth are highlighted for their international medical and recreational cannabis operations.
  • Five stocks to consider instead of Tilray Brands.

Tilray Brands, Akanda, and Canopy Growth are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies that participate in the cannabis industry, including cultivators, processors, distributors, retailers, and ancillary businesses such as equipment suppliers, testing labs, and biotech firms developing cannabis-derived products. For investors, these stocks often carry high volatility and regulatory risk tied to changing federal and state laws, along with the potential for rapid growth as legalization and market acceptance expand. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.

Tilray Brands (TLRY)

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Read Our Latest Research Report on TLRY

Akanda (AKAN)

Read Our Latest Research Report on AKAN

Canopy Growth (CGC)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Read Our Latest Research Report on CGC

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Tilray Brands Right Now?

Before you consider Tilray Brands, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.

While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines